Unknown

Dataset Information

0

Tumour angiogenesis regulation by the miR-200 family.


ABSTRACT: The miR-200 family is well known to inhibit the epithelial-mesenchymal transition, suggesting it may therapeutically inhibit metastatic biology. However, conflicting reports regarding the role of miR-200 in suppressing or promoting metastasis in different cancer types have left unanswered questions. Here we demonstrate a difference in clinical outcome based on miR-200's role in blocking tumour angiogenesis. We demonstrate that miR-200 inhibits angiogenesis through direct and indirect mechanisms by targeting interleukin-8 and CXCL1 secreted by the tumour endothelial and cancer cells. Using several experimental models, we demonstrate the therapeutic potential of miR-200 delivery in ovarian, lung, renal and basal-like breast cancers by inhibiting angiogenesis. Delivery of miR-200 members into the tumour endothelium resulted in marked reductions in metastasis and angiogenesis, and induced vascular normalization. The role of miR-200 in blocking cancer angiogenesis in a cancer-dependent context defines its utility as a potential therapeutic agent.

SUBMITTER: Pecot CV 

PROVIDER: S-EPMC3904438 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

altmetric image

Publications

Tumour angiogenesis regulation by the miR-200 family.

Pecot Chad V CV   Rupaimoole Rajesha R   Yang Da D   Akbani Rehan R   Ivan Cristina C   Lu Chunhua C   Wu Sherry S   Han Hee-Dong HD   Shah Maitri Y MY   Rodriguez-Aguayo Cristian C   Bottsford-Miller Justin J   Liu Yuexin Y   Kim Sang Bae SB   Unruh Anna A   Gonzalez-Villasana Vianey V   Huang Li L   Zand Behrouz B   Moreno-Smith Myrthala M   Mangala Lingegowda S LS   Taylor Morgan M   Dalton Heather J HJ   Sehgal Vasudha V   Wen Yunfei Y   Kang Yu Y   Baggerly Keith A KA   Lee Ju-Seog JS   Ram Prahlad T PT   Ravoori Murali K MK   Kundra Vikas V   Zhang Xinna X   Ali-Fehmi Rouba R   Gonzalez-Angulo Ana-Maria AM   Massion Pierre P PP   Calin George A GA   Calin George A GA   Lopez-Berestein Gabriel G   Zhang Wei W   Sood Anil K AK  

Nature communications 20130101


The miR-200 family is well known to inhibit the epithelial-mesenchymal transition, suggesting it may therapeutically inhibit metastatic biology. However, conflicting reports regarding the role of miR-200 in suppressing or promoting metastasis in different cancer types have left unanswered questions. Here we demonstrate a difference in clinical outcome based on miR-200's role in blocking tumour angiogenesis. We demonstrate that miR-200 inhibits angiogenesis through direct and indirect mechanisms  ...[more]

Similar Datasets

| S-EPMC5630443 | biostudies-literature
| S-EPMC4890021 | biostudies-literature
2011-09-15 | GSE27977 | GEO
| S-EPMC9926042 | biostudies-literature
| S-EPMC8567594 | biostudies-literature
| S-EPMC8247948 | biostudies-literature
2011-09-14 | E-GEOD-27977 | biostudies-arrayexpress
| S-EPMC2867670 | biostudies-literature
| S-EPMC7859396 | biostudies-literature
| S-EPMC6201355 | biostudies-literature